Cellectis S.A.
CMVLF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $42 | $1 | $19 | $74 |
| % Growth | 5,397.5% | -96.1% | -74.1% | – |
| Cost of Goods Sold | $0 | $1 | $2 | $36 |
| Gross Profit | $42 | $0 | $17 | $38 |
| % Margin | 100% | 2.4% | 90.8% | 50.9% |
| R&D Expenses | $91 | $88 | $98 | $87 |
| G&A Expenses | $18 | $17 | $17 | $38 |
| SG&A Expenses | $18 | $15 | $17 | $44 |
| Sales & Mktg Exp. | $0 | -$2 | $0 | $6 |
| Other Operating Expenses | -$7 | $0 | $0 | $0 |
| Operating Expenses | $101 | $90 | $107 | $123 |
| Operating Income | -$60 | -$109 | -$90 | -$85 |
| % Margin | -143.5% | -14,418.2% | -467.7% | -115.5% |
| Other Income/Exp. Net | $23 | -$8 | -$9 | $3 |
| Pre-Tax Income | -$37 | -$116 | -$99 | -$97 |
| Tax Expense | $0 | $0 | $0 | -$11 |
| Net Income | -$37 | -$103 | -$106 | -$81 |
| % Margin | -88.6% | -13,665.4% | -553.6% | -109.6% |
| EPS | -0.41 | -1.77 | -2.33 | -1.81 |
| % Growth | 76.8% | 24% | -28.7% | – |
| EPS Diluted | -0.41 | -1.77 | -2.33 | -1.81 |
| Weighted Avg Shares Out | 91 | 57 | 46 | 45 |
| Weighted Avg Shares Out Dil | 91 | 57 | 46 | 45 |
| Supplemental Information | – | – | – | – |
| Interest Income | $11 | $4 | $1 | $1 |
| Interest Expense | $7 | $7 | $17 | $5 |
| Depreciation & Amortization | $19 | $19 | $19 | $14 |
| EBITDA | -$15 | -$93 | -$76 | -$83 |
| % Margin | -36.5% | -12,269.7% | -398.4% | -112.4% |